NJ State Employees Deferred Compensation Plan’s Eli Lilly LLY Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,210	Closed	-$13.9M	–	229
2025 Q3	$13.9M	Buy	18,210 +1,050	+6%	+$781K	1.53%	9
2025 Q2	$13.4M	Hold	17,160	–	–	1.58%	8
2025 Q1	$14.2M	Hold	17,160	–	–	1.82%	8
2024 Q4	$13.2M	Hold	17,160	–	–	1.61%	8
2024 Q3	$15.2M	Hold	17,160	–	–	1.81%	7
2024 Q2	$15.5M	Sell	17,160 -3,400	-17%	-$2.72M	1.93%	7
2024 Q1	$16M	Sell	20,560 -1,100	-5%	-$783K	2.03%	7
2023 Q4	$12.6M	Sell	21,660 -900	-4%	-$525K	1.74%	6
2023 Q3	$12.1M	Sell	22,560 -1,900	-8%	-$979K	1.84%	5
2023 Q2	$11.5M	Hold	24,460	–	–	1.66%	5
2023 Q1	$8.4M	Hold	24,460	–	–	1.3%	8
2022 Q4	$8.95M	Sell	24,460 -1,800	-7%	-$638K	1.45%	7
2022 Q3	$8.49M	Hold	26,260	–	–	1.46%	6
2022 Q2	$8.51M	Hold	26,260	–	–	1.39%	7
2022 Q1	$7.52M	Hold	26,260	–	–	1.02%	11
2021 Q4	$7.25M	Hold	26,260	–	–	0.91%	15
2021 Q3	$6.07M	Hold	26,260	–	–	0.82%	17
2021 Q2	$6.03M	Hold	26,260	–	–	0.8%	19
2021 Q1	$4.91M	Sell	26,260 -2,300	-8%	-$450K	0.7%	24
2020 Q4	$4.82M	Hold	28,560	–	–	0.74%	21
2020 Q3	$4.23M	Hold	28,560	–	–	0.76%	21
2020 Q2	$4.69M	Hold	28,560	–	–	0.88%	16
2020 Q1	$3.96M	Hold	28,560	–	–	0.91%	17
2019 Q4	$3.75M	Hold	28,560	–	–	0.64%	30
2019 Q3	$3.19M	Buy	28,560 +4,600	+19%	+$512K	0.58%	34
2019 Q2	$2.65M	Hold	23,960	–	–	0.48%	50
2019 Q1	$3.11M	Sell	23,960 -1,040	-4%	-$126K	0.57%	33
2018 Q4	$2.89M	Sell	25,000 -10,000	-29%	-$1.12M	0.6%	32
2018 Q3	$3.76M	Hold	35,000	–	–	0.64%	29
2018 Q2	$2.99M	Hold	35,000	–	–	0.53%	40
2018 Q1	$2.71M	Hold	35,000	–	–	0.48%	50
2017 Q4	$2.96M	Hold	35,000	–	–	0.51%	44
2017 Q3	$2.99M	Hold	35,000	–	–	0.54%	36
2017 Q2	$2.88M	Hold	35,000	–	–	0.54%	39
2017 Q1	$2.94M	Hold	35,000	–	–	0.56%	33
2016 Q4	$2.57M	Hold	35,000	–	–	0.51%	46
2016 Q3	$2.81M	Hold	35,000	–	–	0.58%	37
2016 Q2	$2.76M	Hold	35,000	–	–	0.59%	37
2016 Q1	$2.62M	Hold	35,000	–	–	0.56%	38
2015 Q4	$2.95M	Hold	35,000	–	–	0.6%	33
2015 Q3	$2.93M	Sell	35,000 -10,000	-22%	-$844K	0.63%	29
2015 Q2	$3.76M	Hold	45,000	–	–	0.73%	23
2015 Q1	$3.27M	Hold	45,000	–	–	0.63%	30
2014 Q4	$3.1M	Hold	45,000	–	–	0.61%	33
2014 Q3	$2.92M	Hold	45,000	–	–	0.59%	31
2014 Q2	$2.8M	Hold	45,000	–	–	0.55%	36
2014 Q1	$2.65M	Hold	45,000	–	–	0.54%	36
2013 Q4	$2.29M	Hold	45,000	–	–	0.47%	47
2013 Q3	$2.27M	Hold	45,000	–	–	0.49%	42
2013 Q2	$2.21M	Buy	+45,000	New	+$2.45M	0.51%	39

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's LLY Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 18,210 shares — an estimated $13.9M sold.

NJ State Employees Deferred Compensation Plan first reported a position in LLY in Q2 2013 and held it in 50 quarters. The position peaked at $16M in Q1 2024. 4,429 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

NJ State Employees Deferred Compensation Plan reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 18,210 Eli Lilly shares in Q4 2025, an estimated $13.9M.
NJ State Employees Deferred Compensation Plan first reported a position in Eli Lilly in Q2 2013 and held it in 50 quarters.
NJ State Employees Deferred Compensation Plan's Eli Lilly position peaked at $16M in Q1 2024.
4,429 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.